SREBP-1c overexpression promotes lipogenesis and proliferation, whereas genetic and pharmacological inhibition of SREBP-1c abrogates these effects in ccRCC cells. This evidence concerns the gene SREBF1 and nonpapillary renal cell carcinoma.